BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 32382351)

  • 21. Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.
    Rice TW; Ishwaran H; Hofstetter WL; Kelsen DP; Apperson-Hansen C; Blackstone EH;
    Dis Esophagus; 2016 Nov; 29(8):897-905. PubMed ID: 27905172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.
    Rice TW; Ishwaran H; Blackstone EH; Hofstetter WL; Kelsen DP; Apperson-Hansen C;
    Dis Esophagus; 2016 Nov; 29(8):913-919. PubMed ID: 27905171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.
    Rice TW; Ishwaran H; Kelsen DP; Hofstetter WL; Apperson-Hansen C; Blackstone EH;
    Dis Esophagus; 2016 Nov; 29(8):906-912. PubMed ID: 27905170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging Primer.
    Rice TW; Ishwaran H; Ferguson MK; Blackstone EH; Goldstraw P
    J Thorac Oncol; 2017 Jan; 12(1):36-42. PubMed ID: 27810391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modified Staging Classification for Pancreatic Neuroendocrine Tumors on the Basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems.
    Luo G; Javed A; Strosberg JR; Jin K; Zhang Y; Liu C; Xu J; Soares K; Weiss MJ; Zheng L; Wolfgang CL; Cives M; Wong J; Wang W; Sun J; Shao C; Wang W; Tan H; Li J; Ni Q; Shen L; Chen M; He J; Chen J; Yu X
    J Clin Oncol; 2017 Jan; 35(3):274-280. PubMed ID: 27646952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroendocrine carcinoma of the esophagus: clinical characteristics and prognostic evaluation of 49 cases with surgical resection.
    Deng HY; Ni PZ; Wang YC; Wang WP; Chen LQ
    J Thorac Dis; 2016 Jun; 8(6):1250-6. PubMed ID: 27293844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irinotecan plus cisplatin in patients with extensive-disease poorly differentiated neuroendocrine carcinoma of the esophagus.
    Okuma HS; Iwasa S; Shoji H; Takashima A; Okita N; Honma Y; Kato K; Hamaguchi T; Yamada Y; Shimada Y
    Anticancer Res; 2014 Sep; 34(9):5037-41. PubMed ID: 25202088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical features and treatment modality of esophageal neuroendocrine tumors: a multicenter study in Korea.
    Lee CG; Lim YJ; Park SJ; Jang BI; Choi SR; Kim JK; Kim YT; Cho JY; Yang CH; Chun HJ; Song SY;
    BMC Cancer; 2014 Aug; 14():569. PubMed ID: 25098730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Revised staging classification improves outcome prediction for small intestinal neuroendocrine tumors.
    Kim MK; Warner RR; Roayaie S; Harpaz N; Ward SC; Itzkowitz S; Wisnivesky JP
    J Clin Oncol; 2013 Oct; 31(30):3776-81. PubMed ID: 24043726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary high-grade neuroendocrine carcinoma of the esophagus: a clinicopathologic and immunohistochemical study of 42 resection cases.
    Huang Q; Wu H; Nie L; Shi J; Lebenthal A; Chen J; Sun Q; Yang J; Huang L; Ye Q
    Am J Surg Pathol; 2013 Apr; 37(4):467-83. PubMed ID: 23426118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study.
    ; Cho MY; Kim JM; Sohn JH; Kim MJ; Kim KM; Kim WH; Kim H; Kook MC; Park DY; Lee JH; Chang H; Jung ES; Kim HK; Jin SY; Choi JH; Gu MJ; Kim S; Kang MS; Cho CH; Park MI; Kang YK; Kim YW; Yoon SO; Bae HI; Joo M; Moon WS; Kang DY; Chang SJ
    Cancer Res Treat; 2012 Sep; 44(3):157-65. PubMed ID: 23091441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.
    Rindi G; Falconi M; Klersy C; Albarello L; Boninsegna L; Buchler MW; Capella C; Caplin M; Couvelard A; Doglioni C; Delle Fave G; Fischer L; Fusai G; de Herder WW; Jann H; Komminoth P; de Krijger RR; La Rosa S; Luong TV; Pape U; Perren A; Ruszniewski P; Scarpa A; Schmitt A; Solcia E; Wiedenmann B
    J Natl Cancer Inst; 2012 May; 104(10):764-77. PubMed ID: 22525418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus.
    Maru DM; Khurana H; Rashid A; Correa AM; Anandasabapathy S; Krishnan S; Komaki R; Ajani JA; Swisher SG; Hofstetter WL
    Am J Surg Pathol; 2008 Sep; 32(9):1404-11. PubMed ID: 18670347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The significance of neuroendocrine differentiation in adenocarcinoma of the esophagus and esophagogastric junction after preoperative chemoradiation.
    Wang KL; Yang Q; Cleary KR; Swisher SG; Correa AM; Komaki R; Ajani JA; Rashid A; Hamilton SR; Wu TT
    Cancer; 2006 Oct; 107(7):1467-74. PubMed ID: 16955509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An analysis of 8305 cases of carcinoid tumors.
    Modlin IM; Sandor A
    Cancer; 1997 Feb; 79(4):813-29. PubMed ID: 9024720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation and proposed modification of the 8th edition American Joint Committee on Cancer staging system for patients with esophageal neuroendocrine neoplasms: Evaluation of a revised lymph node classification.
    Wang H; Chen Y; Pi G; Zhu Y; Yang S; Mei H; Lin Z; Zhang T
    Oncol Lett; 2020 Jun; 19(6):4122-4132. PubMed ID: 32382351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers.
    Paner GP; Stadler WM; Hansel DE; Montironi R; Lin DW; Amin MB
    Eur Urol; 2018 Apr; 73(4):560-569. PubMed ID: 29325693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of two major staging systems of esophageal cancer-toward more practical common scale for tumor staging.
    Udagawa H; Ueno M
    Ann Transl Med; 2018 Feb; 6(4):76. PubMed ID: 29666799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revisiting the 8th AJCC system for gastric cancer: A review on validations, nomograms, lymph nodes impact, and proposed modifications.
    Mranda GM; Xue Y; Zhou XG; Yu W; Wei T; Xiang ZP; Liu JJ; Ding YL
    Ann Med Surg (Lond); 2022 Mar; 75():103411. PubMed ID: 35386808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revisions to the Tumor, Node, Metastasis staging of lung cancer (8
    Kay FU; Kandathil A; Batra K; Saboo SS; Abbara S; Rajiah P
    World J Radiol; 2017 Jun; 9(6):269-279. PubMed ID: 28717413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.